Drug profile · INN
moxifloxacin hydrochloride
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin hydrochloride (MOXIFLOXACIN HYDROCHLORIDE) is a bacterial dna gyrase inhibitor. Associated with Sunshine Guojian Pharmaceutical (Shanghai) Co.,. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — moxifloxacin hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
moxifloxacin hydrochloride (MOXIFLOXACIN HYDROCHLORIDE) is a bacterial dna gyrase inhibitor. Associated with Sunshine Guojian Pharmaceutical (Shanghai) Co.,. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial DNA gyrase inhibitor
Primary target: Bacterial DNA gyrase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is moxifloxacin hydrochloride?
moxifloxacin hydrochloride (MOXIFLOXACIN HYDROCHLORIDE) is a bacterial dna gyrase inhibitor. Associated with Sunshine Guojian Pharmaceutical (Shanghai) Co.,. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for moxifloxacin hydrochloride?
MOXIFLOXACIN HYDROCHLORIDE is a marketed brand name for moxifloxacin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of moxifloxacin hydrochloride?
moxifloxacin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.